IP Library Granted Patent US 9,080,200
Granted Patent B2
US 9,080,200 · App. 13/124,964 · Granted Jul 14, 2015

Method of quality control testing a Factor XIII containing sample

Inventors: Mette Dahl Andersen (Værløse, DK); Gunhild K. Kristiansen (Bagsværd, DK); Pernille Charlotte Svane (Søborg, DK); Lene Hørlyck (Birkerød, DK); Mette Schrøder (Valby, DK)
Assignee: Novo Nordisk Healthcare A/G
C12Q1/56G01N33/86G01N2333/91085
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,080,200
App. No.
13/124,964
Granted
Jul 14, 2015
Kind
B2
Abstract

The invention relates to a method of quality control testing a Factor XIII (FXIII) containing sample which comprises the step of detecting the presence of and/or measuring the concentration of pre-activated FXIII (FXIIIao) in said sample and to a quality control kit for determining the quality of a Factor XIII (FXIII) containing sample. Preferably, an anion-exchange chromatographic column is used, as well as the fluorescent substrate Abz-NE (Cad-Dnp) EQVS PLTLLK-OH.

Claims (16)

1. A method of quality control testing a sample containing Factor XIII (FXIII) by determining the level of pre-activated FXIII in the sample, comprising:

measuring activated FXIII in the sample in the absence of thrombin and in the presence of 0.5-10 mM atomic absorption standard Ca 2+ ; and

measuring activated FXIII in the sample in the presence of thrombin and 0.5-10 mM atomic absorption standard Ca 2+ ,

wherein the ratio of (i) activated FXIII in the absence of thrombin to (ii) activated FXIII in the presence of thrombin indicates the level of pre-activated FXIII in the sample.

2. The method according to claim 1 , wherein the measuring steps comprise measuring the activated FXIII in the presence of 1-2 mM atomic absorption standard Ca 2+ .

3. The method according to claim 2 , wherein the measuring steps comprise measuring the activated FXIII in the presence of 2 mM atomic absorption standard Ca 2+ .

4. The method according to claim 1 , wherein the measuring steps are performed in the presence of a fluorometric or non-fluorometric substrate.

5. The method according to claim 4 , wherein the substrate comprises Abz-NE(Cad-Dnp)EQVSPLTLLK.

6. The method according to claim 1 , wherein the measuring steps further comprise measuring the activated FXIII in the presence of 50-500 mM NaCl.

7. The method according to claim 6 , wherein the measuring steps further comprise measuring the activated FXIII in the presence of 100-200 mM NaCl.

8. The method according to claim 1 , wherein the measuring steps further comprise measuring the activated FXIII at a pH between 6.5 and 10.

9. The method according to claim 8 , wherein the measuring steps further comprise measuring the activated FXIII at a pH between 7 and 8.

10. The method according to claim 1 , wherein the measuring steps further comprise measuring the activated FXIII in the presence of 50-200 mM Hepes buffer.

11. The method according to claim 10 , wherein the measuring steps further comprise measuring the activated FXIII in the presence of 100 mM Hepes buffer.

12. The method according to claim 1 , wherein the measuring steps further comprise measuring the activated FXIII in the presence of a surfactant.

13. The method according to claim 12 , wherein the surfactant is a polyethylene glycol.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 19, 2013
From: NOVO NORDISK HEALTHCARE A/G
To: NOVO NORDISK HEALTHCARE AG
Reel/Frame 030656/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2011
From: ANDERSEN, METTE DAHL; KRISTIANSEN, GUNHILD K.; SVANE, PERNILLE CHARLOTTE; HORLYCK, LENE; SCHRODER, METTE
To: NOVO NORDISK HEALTH CARE AG
Reel/Frame 026519/0939 →
Priority Claims (1)
EP 08167476 · Oct 24, 2008 · regional
Continuity (2)
Provisional Application 61109520 · Oct 30, 2008
Related Publication 20110265557A1 · Nov 3, 2011